<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; First</title>
	<atom:link href="http://www.tapanray.in/tag/first/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>MAGA vs. Viksit Bharat: Trump&#8217;s Tariffs And India&#8217;s Pharma Dreams</title>
		<link>http://www.tapanray.in/maga-vs-viksit-bharat-trumps-tariffs-and-indias-pharma-dreams/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=maga-vs-viksit-bharat-trumps-tariffs-and-indias-pharma-dreams</link>
		<comments>http://www.tapanray.in/maga-vs-viksit-bharat-trumps-tariffs-and-indias-pharma-dreams/#comments</comments>
		<pubDate>Tue, 15 Apr 2025 08:32:05 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[America]]></category>
		<category><![CDATA[bharat]]></category>
		<category><![CDATA[dreams]]></category>
		<category><![CDATA[First]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[MAGA]]></category>
		<category><![CDATA[Modi]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[reciprocal]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[Tariff]]></category>
		<category><![CDATA[threat]]></category>
		<category><![CDATA[Trump]]></category>
		<category><![CDATA[Vikshit]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=10888</guid>
		<description><![CDATA[A high-stakes clash poses a potential threat to PM Modi&#8217;s &#8216;Viksit Bharat&#8217; Vision, exposing India&#8217;s pharmaceutical vulnerability and forcing a strategic reckoning. The resurgence of Donald Trump&#8217;s &#8220;America First&#8221; MAGA (Make America Great Again) agenda casts a long, ominous shadow &#8230; <a href="http://www.tapanray.in/maga-vs-viksit-bharat-trumps-tariffs-and-indias-pharma-dreams/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/maga-vs-viksit-bharat-trumps-tariffs-and-indias-pharma-dreams/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>With Covid’s Second Wave ‘A Nation In Distress’ &#8211; Why?</title>
		<link>http://www.tapanray.in/with-covids-second-wave-a-nation-in-distress-why/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=with-covids-second-wave-a-nation-in-distress-why</link>
		<comments>http://www.tapanray.in/with-covids-second-wave-a-nation-in-distress-why/#comments</comments>
		<pubDate>Mon, 19 Apr 2021 00:00:10 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[A Nation in distress]]></category>
		<category><![CDATA[Challenges]]></category>
		<category><![CDATA[clinically]]></category>
		<category><![CDATA[Covid]]></category>
		<category><![CDATA[COVID-19]]></category>
		<category><![CDATA[Covishield]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[First]]></category>
		<category><![CDATA[global]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[pandemic]]></category>
		<category><![CDATA[Pharmacy]]></category>
		<category><![CDATA[proven]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Second]]></category>
		<category><![CDATA[shortage]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[Vaccine]]></category>
		<category><![CDATA[wave]]></category>
		<category><![CDATA[World]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=10475</guid>
		<description><![CDATA[If someone tries to see a silver lining in the disruptive Covid-19 pandemic, besides its vaccine rollout in some countries, there will be at least one. As of April 17, 2021- over 119 million patients (India &#8211; over 12 million), reportedly, &#8230; <a href="http://www.tapanray.in/with-covids-second-wave-a-nation-in-distress-why/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/with-covids-second-wave-a-nation-in-distress-why/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>India Not To Vaccinate All For Covid Control: Upsides And Unknowns</title>
		<link>http://www.tapanray.in/india-not-to-vaccinate-all-for-covid-control-upsides-and-unknowns/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=india-not-to-vaccinate-all-for-covid-control-upsides-and-unknowns</link>
		<comments>http://www.tapanray.in/india-not-to-vaccinate-all-for-covid-control-upsides-and-unknowns/#comments</comments>
		<pubDate>Mon, 07 Dec 2020 00:00:18 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[All]]></category>
		<category><![CDATA[AstraZeneca]]></category>
		<category><![CDATA[authorization]]></category>
		<category><![CDATA[citizen]]></category>
		<category><![CDATA[control]]></category>
		<category><![CDATA[Coronavirus]]></category>
		<category><![CDATA[Covid]]></category>
		<category><![CDATA[COVID-19]]></category>
		<category><![CDATA[emergency-use]]></category>
		<category><![CDATA[First]]></category>
		<category><![CDATA[group]]></category>
		<category><![CDATA[immunity]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Moderna]]></category>
		<category><![CDATA[Modi]]></category>
		<category><![CDATA[Oxford]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[plan]]></category>
		<category><![CDATA[Prime Minister]]></category>
		<category><![CDATA[Priority]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Regulatory]]></category>
		<category><![CDATA[Sputnik V]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[U.K]]></category>
		<category><![CDATA[unknowns]]></category>
		<category><![CDATA[upsides]]></category>
		<category><![CDATA[Vaccinate]]></category>
		<category><![CDATA[Vaccine]]></category>
		<category><![CDATA[work in progress]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=10355</guid>
		<description><![CDATA[With 9.46 million cases and 137,621 deaths, India has currently the world’s second-highest number of coronavirus infections, behind only the United States, reported Reuters on December 01, 2020. Fathoming seriousness of rapidly unfolding Covid induced all round disruptions across the nation, on &#8230; <a href="http://www.tapanray.in/india-not-to-vaccinate-all-for-covid-control-upsides-and-unknowns/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/india-not-to-vaccinate-all-for-covid-control-upsides-and-unknowns/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Vaccines Development: Is it Just a Business Based on Fear?</title>
		<link>http://www.tapanray.in/vaccines-development-is-it-just-a-business-based-on-fear/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=vaccines-development-is-it-just-a-business-based-on-fear</link>
		<comments>http://www.tapanray.in/vaccines-development-is-it-just-a-business-based-on-fear/#comments</comments>
		<pubDate>Mon, 26 Aug 2013 00:00:26 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Based]]></category>
		<category><![CDATA[Bill]]></category>
		<category><![CDATA[Buchwald]]></category>
		<category><![CDATA[Business]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Costs]]></category>
		<category><![CDATA[diphtheria]]></category>
		<category><![CDATA[disease]]></category>
		<category><![CDATA[enough]]></category>
		<category><![CDATA[Expenses]]></category>
		<category><![CDATA[fear]]></category>
		<category><![CDATA[First]]></category>
		<category><![CDATA[Gates]]></category>
		<category><![CDATA[GAVI]]></category>
		<category><![CDATA[Gerhard]]></category>
		<category><![CDATA[global]]></category>
		<category><![CDATA[growth]]></category>
		<category><![CDATA[GSK]]></category>
		<category><![CDATA[HIV]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[JV]]></category>
		<category><![CDATA[local]]></category>
		<category><![CDATA[malaria]]></category>
		<category><![CDATA[market]]></category>
		<category><![CDATA[Merck]]></category>
		<category><![CDATA[MSD]]></category>
		<category><![CDATA[NCD]]></category>
		<category><![CDATA[New]]></category>
		<category><![CDATA[NIH]]></category>
		<category><![CDATA[Not]]></category>
		<category><![CDATA[Novartis]]></category>
		<category><![CDATA[Partnership]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[pox]]></category>
		<category><![CDATA[prevention]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[research]]></category>
		<category><![CDATA[Sanofi]]></category>
		<category><![CDATA[small]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[TB]]></category>
		<category><![CDATA[threat]]></category>
		<category><![CDATA[Tuberculosis]]></category>
		<category><![CDATA[vaccination]]></category>
		<category><![CDATA[vaccines]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=3486</guid>
		<description><![CDATA[‘Vaccination – A Business based on fear’, is the title of a book written by Dr. Gerhard Buchwald M.D, a German medical doctor and a vaccination critic. This book talks about: “The damage and the deaths caused by vaccination are written &#8230; <a href="http://www.tapanray.in/vaccines-development-is-it-just-a-business-based-on-fear/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/vaccines-development-is-it-just-a-business-based-on-fear/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>First ever &#8216;Code of Pharma Marketing Practices&#8217; by the Government: A strong signal to &#8220;Shape Up&#8221;!</title>
		<link>http://www.tapanray.in/first-ever-code-of-pharma-marketing-practices-by-the-government-a-strong-signal-to-shape-up/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=first-ever-code-of-pharma-marketing-practices-by-the-government-a-strong-signal-to-shape-up</link>
		<comments>http://www.tapanray.in/first-ever-code-of-pharma-marketing-practices-by-the-government-a-strong-signal-to-shape-up/#comments</comments>
		<pubDate>Mon, 18 Jul 2011 00:00:34 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[by]]></category>
		<category><![CDATA[Code]]></category>
		<category><![CDATA[Department]]></category>
		<category><![CDATA[ever]]></category>
		<category><![CDATA[First]]></category>
		<category><![CDATA[Government]]></category>
		<category><![CDATA[Malpractices]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[of pharmaceuticals]]></category>
		<category><![CDATA[practices]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Shape]]></category>
		<category><![CDATA[signal]]></category>
		<category><![CDATA[Strong]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[to]]></category>
		<category><![CDATA[Up]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=227</guid>
		<description><![CDATA[After a protracted debate on the alleged ‘unethical marketing practices’ by the pharmaceutical companies, in May 2011, the Department of Pharmaceuticals (DoP) came out with a draft ‘Uniform Code of Pharmaceutical Marketing Practices (UCMP)’ to address this issue squarely and &#8230; <a href="http://www.tapanray.in/first-ever-code-of-pharma-marketing-practices-by-the-government-a-strong-signal-to-shape-up/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/first-ever-code-of-pharma-marketing-practices-by-the-government-a-strong-signal-to-shape-up/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>&#8216;India Taskforce&#8217; takes the first step in an arduous task to bridge the trust deficit.</title>
		<link>http://www.tapanray.in/india-taskforce-takes-the-first-step-in-an-arduous-task-to-bridge-the-trust-deficit/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=india-taskforce-takes-the-first-step-in-an-arduous-task-to-bridge-the-trust-deficit</link>
		<comments>http://www.tapanray.in/india-taskforce-takes-the-first-step-in-an-arduous-task-to-bridge-the-trust-deficit/#comments</comments>
		<pubDate>Mon, 13 Jun 2011 00:00:31 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[an]]></category>
		<category><![CDATA[arduous]]></category>
		<category><![CDATA[bridge]]></category>
		<category><![CDATA[deficit]]></category>
		<category><![CDATA[First]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[industry]]></category>
		<category><![CDATA[infrastructure]]></category>
		<category><![CDATA[investments]]></category>
		<category><![CDATA[ministry of health]]></category>
		<category><![CDATA[MoH]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[step]]></category>
		<category><![CDATA[takes]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[task]]></category>
		<category><![CDATA[Taskforce]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[to]]></category>
		<category><![CDATA[trust]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=244</guid>
		<description><![CDATA[To prepare a comprehensive long term strategy to unleash the growth potential of the Pharmaceutical Industry of India considering all its current issues, the Ministry of Health and Family Welfare announced constitution of a taskforce on March 15, 2011 involving &#8230; <a href="http://www.tapanray.in/india-taskforce-takes-the-first-step-in-an-arduous-task-to-bridge-the-trust-deficit/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/india-taskforce-takes-the-first-step-in-an-arduous-task-to-bridge-the-trust-deficit/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The First Pharmaceuticals Census of India – a commendable initiative by the National Pharmaceutical Pricing Authority (NPPA)</title>
		<link>http://www.tapanray.in/the-first-pharmaceuticals-census-of-india-a-commendable-initiative-by-the-national-pharmaceutical-pricing-authority-nppa/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-first-pharmaceuticals-census-of-india-a-commendable-initiative-by-the-national-pharmaceutical-pricing-authority-nppa</link>
		<comments>http://www.tapanray.in/the-first-pharmaceuticals-census-of-india-a-commendable-initiative-by-the-national-pharmaceutical-pricing-authority-nppa/#comments</comments>
		<pubDate>Mon, 12 Jul 2010 01:00:57 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Authority]]></category>
		<category><![CDATA[by]]></category>
		<category><![CDATA[Census]]></category>
		<category><![CDATA[commendable]]></category>
		<category><![CDATA[First]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Initiative]]></category>
		<category><![CDATA[National]]></category>
		<category><![CDATA[NPPA]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Pricing]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=403</guid>
		<description><![CDATA[Currently there is indeed a crying need for the pharmaceutical industry to generate a robust data base to formulate not only various healthcare related policies, but also to measure the level of their effective implementation. In the absence of such &#8230; <a href="http://www.tapanray.in/the-first-pharmaceuticals-census-of-india-a-commendable-initiative-by-the-national-pharmaceutical-pricing-authority-nppa/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/the-first-pharmaceuticals-census-of-india-a-commendable-initiative-by-the-national-pharmaceutical-pricing-authority-nppa/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
